Natera, INC Form 4 insider transactions

Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.

NASDAQ
Jonathan Sheena, a Director of Natera, Inc., sold 1,500 shares of common stock on October 16, 2026.
NASDAQ
Matthew Rabinowitz, EXECUTIVE CHAIRMAN and a Director of Natera, Inc., sold 50,000 shares of common stock on October 15, 2026.
NASDAQ
Matthew Rabinowitz, EXECUTIVE CHAIRMAN and a Director of Natera, Inc., reported a transaction in 6,000 shares of common stock on October 7, 2026.
NASDAQ
Steven Leonard Chapman, CEO AND PRESIDENT and a Director of Natera, Inc., sold 1,273 shares of common stock on October 1, 2026 for $413.31 per share.
NASDAQ
Solomon Moshkevich, PRESIDENT, CLINICALDIAGNOSTICS of Natera, Inc., sold 3,000 shares of common stock on October 1, 2026.
NASDAQ
Jonathan Sheena, a Director of Natera, Inc., sold 18,064 shares of common stock on September 23, 2026.
NASDAQ
Solomon Moshkevich, PRESIDENT, CLINICALDIAGNOSTICS of Natera, Inc., reported a transaction in 945 shares of common stock on September 16, 2026.
NASDAQ
Jonathan Sheena, a Director of Natera, Inc., sold 9,150 shares of common stock on September 15, 2026.
NASDAQ
Matthew Rabinowitz, EXECUTIVE CHAIRMAN and a Director of Natera, Inc., sold 102,000 shares of common stock on September 14, 2026.
NASDAQ
Matthew Rabinowitz, EXECUTIVE CHAIRMAN and a Director of Natera, Inc., sold 50,000 shares of common stock on September 11, 2026.
NASDAQ
Solomon Moshkevich, PRESIDENT, CLINICALDIAGNOSTICS of Natera, Inc., sold 18,160 shares of common stock on September 1, 2026.
NASDAQ
Steven Leonard Chapman, CEO AND PRESIDENT and a Director of Natera, Inc., sold 1,698 shares of common stock on September 1, 2026 for $320.99 per share.
NASDAQ
John Fesko, PRESIDENT, CHIEF BUS. OFFICER of Natera, Inc., sold 6,517 shares of common stock on August 6, 2026 for $321.53 per share.
NASDAQ
Jonathan Sheena, a Director of Natera, Inc., sold 6,000 shares of common stock on August 10, 2026 for $325.32 per share.
NASDAQ
Matthew Rabinowitz, EXECUTIVE CHAIRMAN and a Director of Natera, Inc., sold 2,000 shares of common stock on August 7, 2026 for $320.90 per share.
NASDAQ
Jonathan Sheena, a Director of Natera, Inc., sold 9,150 shares of common stock on August 7, 2026.
NASDAQ
Michael Burkes Brophy, CHIEF FINANCIAL OFFICER of Natera, Inc., sold 795 shares of common stock on August 3, 2026.
NASDAQ
Steven Leonard Chapman, CEO AND PRESIDENT and a Director of Natera, Inc., sold 3,076 shares of common stock on August 3, 2026.
NASDAQ
John Fesko, PRESIDENT, CHIEF BUS. OFFICER of Natera, Inc., sold 295 shares of common stock on August 3, 2026 for $267.99 per share.
NASDAQ
Solomon Moshkevich, PRESIDENT, CLINICALDIAGNOSTICS of Natera, Inc., sold 3,410 shares of common stock on August 3, 2026.
NASDAQ
Daniel Rabinowitz, SEC. AND CHIEF LEGAL OFFICER of Natera, Inc., sold 334 shares of common stock on August 3, 2026 for $267.99 per share.
NASDAQ
Matthew Rabinowitz, EXECUTIVE CHAIRMAN and a Director of Natera, Inc., sold 731 shares of common stock on August 3, 2026 for $267.99 per share.
NASDAQ
Jonathan Sheena, a Director of Natera, Inc., sold 109 shares of common stock on August 3, 2026 for $267.99 per share.
NASDAQ
Jonathan Sheena, a Director of Natera, Inc., sold 479 shares of common stock on July 27, 2026.
NASDAQ
Matthew Rabinowitz, EXECUTIVE CHAIRMAN and a Director of Natera, Inc., sold 1,718 shares of common stock on July 27, 2026 for $260.49 per share.
NASDAQ
Daniel Rabinowitz, SEC. AND CHIEF LEGAL OFFICER of Natera, Inc., sold 1,887 shares of common stock on July 27, 2026.
NASDAQ
Solomon Moshkevich, PRESIDENT, CLINICALDIAGNOSTICS of Natera, Inc., sold 2,214 shares of common stock on July 27, 2026.
NASDAQ
John Fesko, PRESIDENT, CHIEF BUS. OFFICER of Natera, Inc., sold 1,713 shares of common stock on July 27, 2026.
NASDAQ
Steven Leonard Chapman, CEO AND PRESIDENT and a Director of Natera, Inc., sold 5,770 shares of common stock on July 27, 2026.
NASDAQ
Michael Burkes Brophy, CHIEF FINANCIAL OFFICER of Natera, Inc., sold 5,064 shares of common stock on July 27, 2026.